Jazz Pharmaceuticals Plc - Company Profile
Powered by
All the data and insights you need on Jazz Pharmaceuticals Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Jazz Pharmaceuticals Plc Strategy Report
- Understand Jazz Pharmaceuticals Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Jazz Pharmaceuticals Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
04 May 2022 | Jazz Pharma Enters into Licensing Agreement with Sumitomo Pharma | Licensing Agreement |
Jazz Pharmaceuticals Plc
|
Sumitomo Pharmaceuticals Co., Ltd. (Inactive)
|
07 Apr 2022 | Jazz Pharma Enters into Licensing Agreement with Werewolf Therapeutics | Licensing Agreement |
Jazz Pharmaceuticals Plc
|
Werewolf Therapeutics Inc
|
28 Mar 2022 | Axsome Therapeutics Acquires US Rights of Sunosi (solriamfetol) from Jazz Pharma | Asset Transaction |
Axsome Therapeutics Inc
|
Jazz Pharmaceuticals Plc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer